Income Tax Expense (Benefit) in USD of Fortress Biotech, Inc. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Fortress Biotech, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to Q3 2025.
  • Fortress Biotech, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $26K, a 62.3% decline year-over-year.
  • Fortress Biotech, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $269K, a 40.1% decline year-over-year.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2024 was $312K, a 40.1% decline from 2023.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2023 was $521K, a 16% increase from 2022.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2022 was $449K, a 5.07% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

Fortress Biotech, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $269K $26K -$43K -62.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $312K $0 $0 Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $312K $0 $0 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $312K $243K -$137K -36.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $449K $69K -$72K -51.1% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 $521K $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $521K $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $521K $380K -$69K -15.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $590K $141K +$141K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $449K $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $449K $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $449K $449K -$24K -5.07% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $473K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $473K $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $473K $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $473K $473K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2018 $944K +$944K Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $1.44M +$1.44M Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q4 2017 $1.51M $1.51M Oct 1, 2017 Dec 31, 2017 10-K 2018-03-16
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-K 2018-03-16

Fortress Biotech, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $312K -$209K -40.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $521K +$72K +16% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $449K -$24K -5.07% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $473K -$27K -5.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $500K +$500K Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
2018 $0 -$1.51M -100% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $1.51M +$1.51M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.